Capromab Pendetide immunoscintigraphy: connecting the dots for prostate cancer imaging.
Manyak
M J
MJ
D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D000465:Algorithms; D000911:Antibodies, Monoclonal; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005188:False Negative Reactions; D006801:Humans; D016015:Logistic Models; D008207:Lymphatic Metastasis; D008297:Male; D015337:Multicenter Studies as Topic; D011237:Predictive Value of Tests; D011300:Preoperative Care; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D016719:Radioimmunodetection; D012306:Risk; D016879:Salvage Therapy; D015899:Tomography, Emission-Computed, Single-Photon
D000911:Antibodies, Monoclonal; C101315:Capromab Pendetide